TITLE

Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction

AUTHOR(S)
Sandford, A. J.; Silverman, E. K.
PUB. DATE
August 2002
SOURCE
Thorax;Aug2002, Vol. 57 Issue 8, p736
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Genetic factors including alpha(1)-antitrypsin deficiency are important in COPD. Candidate gene association studies in COPD are reviewed. Efforts to identify interactions between genetic factors and environmental determinants such as smoking may lead to improved understanding of the pathogenesis of the disease.
ACCESSION #
13221437

 

Related Articles

  • Alpha-1-Antitrypsin Deficiency: Current Concepts. Mulgrew, Alan T.; Taggart, Clifford C.; McElvaney, N. Gerry // Lung;Jul/Aug2007, Vol. 185 Issue 4, p191 

    Since the condition was first described four decades ago, alpha-1-antitrypsin (A1AT) deficiency has served as a model for other disease processes. A1AT is the archetypal serpin designed to ensnare proteases, a process that involves significant conformational change within the molecule. Mutations...

  • Genetic and Environmental Determinants of Chronic Obstructive Pulmonary Disease. Larson, Roger K.; Barman, Martin L.; Keuppers, Friedrich; Fudenberg, Hugh // Annals of Internal Medicine;May70, Vol. 72 Issue 5, p627 

    The prevalence of abnormalities of pulmonary function among 156 relatives of 61 patients with chronic obstructive pulmonary disease was found to be significantly higher than the prevalence in a control group of their spouses. No relationship of this increased familial prevalence to...

  • Obstructive Lung Disease in Heterozygotes for Alpha-1 Antitrypsin Deficiency. Kueppers, Friedrich; Donhardt, Axel // Annals of Internal Medicine;Feb74, Vol. 80 Issue 2, p209 

    Presents a study which examined the association of heterozygosity for alpha-1 antitrypsin deficiency with chronic obstructive lung disease. Clinical characteristics of the patients; Laboratory examinations conducted; Findings and its implications.

  • Development of Predictive Models for Airflow Obstruction in Alpha-1-Antitrypsin Deficiency. Castaldi, P. J.; DeMeo, D. L.; Kent, D. M.; Campbell, E. J.; Barker, A. F.; Brantly, M. L.; Eden, E.; McElvaney, N. G.; Rennard, S. I.; Stocks, J. M.; Stoller, J. K.; Strange, C.; Turino, G.; Sandhaus, R. A.; Griffith, J. L.; Silverman, E. K. // American Journal of Epidemiology;Oct2009, Vol. 170 Issue 8, p1005 

    Alpha-1-antitrypsin deficiency is a genetic condition associated with severe, early-onset chronic obstructive pulmonary disease (COPD). However, there is significant variability in lung function impairment among persons with the protease inhibitor ZZ genotype. Early identification of persons at...

  • Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults. Ngo, Leock Y.; Haeberle, Adam; Dyck-Jones, Jacqueline; Gelmont, David; Yel, Leman // Open Access Journal of Clinical Trials;2014, Vol. 6, p55 

    Purpose: Alpha1-proteinase inhibitor (A1PI) is indicated for chronic augmentation therapy in adults with emphysema due to congenital deficiency of A1PI. An intravenous infusion rate of 0.04 mL/kg/minute is currently recommended for the A1PI product, Glassia®. This randomized, placebo-masked,...

  • Chronic obstructive pulmonary disease. Knott, Laurence // GP: General Practitioner;5/30/2008, p26 

    The discusses the chronic obstructive pulmonary disease (COPD). Patients who are diagnosed with chronic bronchitis or emphysema acquired COPD. The risk factors of COPD including smoking, exposure to noxious gases and particles and hereditary alpha1-antitrypsin deficiency are discussed. It offers...

  • SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort. Thun, Gian-Andri; Ferrarotti, Ilaria; Imboden, Medea; Rochat, Thierry; Gerbase, Margaret; Kronenberg, Florian; Bridevaux, Pierre-Olivier; Zemp, Elisabeth; Zorzetto, Michele; Ottaviani, Stefania; Russi, Erich W.; Luisetti, Maurizio; Probst-Hensch, Nicole M.; de Torres, Juan P. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD. But the impact of gene variants resulting in mild or intermediate AAT deficiency on the longitudinal course of respiratory health remains controversial. There is indication from experimental studies that...

  • Smoking and COPD: the impact of nature-nurture interactions. Clancy, John; Turner, Christopher // British Journal of Nursing;7/25/2013, Vol. 22 Issue 14, p820 

    The maintenance of health (homeostasis) and the occurrence of disease such as chronic obstructive pulmonary disease (COPD) are acquired through nature-nurture interactions. The inherited genotype of a person is responsible for producing a deficiency of enzymes called anti-proteases, such as...

  • Alpha-1 Antitrypsin Deficiency Is Not a Rare Disease but a Disease That Is Rarely Diagnosed. de Serres, Frederick J. // Environmental Health Perspectives;Dec2003, Vol. 111 Issue 16, p1851 

    Articles in the literature on alpha-1 antitrypsin (AAT) deficiency have been interpreted as indicating that AAT deficiency is a rare disease that affects mainly Caucasians (whites) from northern Europe. In a recent publication on the worldwide racial and ethnic distribution of AAT deficiency,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics